Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Novel Role of Histone Deacetylase 11 (HDAC11) in the Regulation of IL-10 Production and Immune Tolerance Mediated by Antigen-Presenting Cells.

Hongwei Wang, MD, Fengdong Cheng, M.D, D. Nguyen, M.D, I. Suarez, Phd, K. Wright, Phd, A.P. Atadja, Phd, E. Seto, Phd, K. Bhalla, M.D, A. Villagra, Phd, E.M. Sotomayor, M.D

Blood (2007) 110 (11): 1330.

https://doi.org/10.1182/blood.V110.11.1330.1330

Published: 2007

Journal Articles

Enhancement of the Antigen-Presenting Cell Function of Mantle Cell Lymphomas (MCL) by Novel Molecularly Based Immunotherapeutic Strategies.

Hongwei Wang, MD, Fengdong Cheng, D. Noyes, K. Wright, S. Mohapatra, J. Tao, M. Schell, S. Sebti, M. Smith, K. Bhalla, J. Pinilla, S. Dessureault, D. Celis, E.M. Sotomayor, (Intr. by Eduardo M. Sotomayor)

Blood (2007) 110 (11): 2315.

https://doi.org/10.1182/blood.V110.11.2315.2315

Published: 2007

Journal Articles

Measurement of Free Circulating Bcr-Abl Fusion Protein and Its Phosphorylation in Patients with Chronic Myeloid Leukemia.

I. Jilani, H. Kantarjian, H. Faraji, M. Gorre, J. Cortes, O. Ottmann, K. Bhalla, S. O’Brien, F. Giles, M. Albitar

Blood (2005) 106 (11): 2006.

https://doi.org/10.1182/blood.V106.11.2006.2006

Published: 2005

Journal Articles

Phosphorylation Levels of BCR-ABL, Stat5, and CrkL Proteins in Imatinib-Resistant CML Patients as Compared to Previously Untreated CML Patients: Implication of Poor Drug Binding and Activation of Alternate Pathways.

M. Gorre, H. Kantarjian, I. Jilani, J. Cortes, A. Salvado, P. Rae, L. Alland, M. Dugan, O. Ottmann, K. Bhalla, F. Giles, M. Albitar

Blood (2005) 106 (11): 2001.

https://doi.org/10.1182/blood.V106.11.2001.2001

Published: 2005

Journal Articles

AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL).

Hagop M. Kantarjian, MD, O. Ottman, MD, Jorge Cortes, MD, M. Wassman, MD, L. Wunderle, MD, K. Bhalla, MD, D. Jones, MD, A. Hochhaus, MD, P. Rae, L. Alland, MD, M. Dugan, MD, M. Albitar, MD, Francis Giles, MD

Blood (2005) 106 (11): 37.

https://doi.org/10.1182/blood.V106.11.37.37

Published: 2005

Journal Articles

Discrepancy in Detecting Bcr-Abl Kinase Domain Mutations between Cells from Bone Marrow and Cells from Peripheral Blood, and Greater Concordance between Bone Marrow Cells and Plasma Free RNA.

W. Ma, H. Kantarjian, I. Jilani, M. Gorre, Ottmann, K. Bhalla, F. Giles, M. Albitar

Blood (2005) 106 (11): 4849.

https://doi.org/10.1182/blood.V106.11.4849.4849

Published: 2005

Journal Articles

Treatment of Antigen-Presenting Cells with Histone Deacetylase Inhibitors Represents a Novel Strategy To Overcome CD4+ T-Cell Tolerance: Divergent Effects on the IL10 and IL-12 Promoter.

Hongwei Wang, MD, Fengdong Cheng, MD, P. Horna, MD, I.V. Suarez, PhD, Jian Wu, PhD, A.P. Atadja, PhD, E. Seto, PhD, K. Wright, PhD, K. Bhalla, MD, E.M. Sotomayor, MD

Blood (2005) 106 (11): 2392.

https://doi.org/10.1182/blood.V106.11.2392.2392

Published: 2005

Journal Articles

Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells

JE Brandt, K Bhalla, R Hoffman

Blood (1994) 83 (6): 1507–1514.

https://doi.org/10.1182/blood.V83.6.1507.1507

Published: 1994

Journal Articles

High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells

K Bhalla, AM Ibrado, E Tourkina, C Tang, S Grant, G Bullock, Y Huang, V Ponnathpur, ME Mahoney

Blood (1993) 82 (10): 3133–3140.

https://doi.org/10.1182/blood.V82.10.3133.3133

Published: 1993

Journal Articles

Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells

K Bhalla, C Tang, AM Ibrado, S Grant, E Tourkina, C Holladay, M Hughes, ME Mahoney, Y Huang

Blood (1992) 80 (11): 2883–2890.

https://doi.org/10.1182/blood.V80.11.2883.2883

Published: 1992

Journal Articles

Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells

K Bhalla, P Swerdlow, S Grant

Blood (1991) 78 (11): 2937–2944.

https://doi.org/10.1182/blood.V78.11.2937.2937

Published: 1991

Journal Articles

Treatment with interleukin-3 plus granulocyte-macrophage colony- stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts

K Bhalla, C Holladay, Z Arlin, S Grant, AM Ibrado, M Jasiok

Blood (1991) 78 (10): 2674–2679.

https://doi.org/10.1182/blood.V78.10.2674.2674

Published: 1991

Journal Articles

2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity

K Bhalla, M Birkhofer, GR Li, S Grant, W MacLaughlin, J Cole, G Graham, DJ Volsky

Blood (1989) 74 (6): 1923–1928.

https://doi.org/10.1182/blood.V74.6.1923.1923

Published: 1989

Journal Articles

Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity

K Bhalla, W MacLaughlin, J Cole, Z Arlin, M Baker, G Graham, S Grant

Blood (1987) 70 (2): 568–571.

https://doi.org/10.1182/blood.V70.2.568.568

Published: 1987

Journal Articles

Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1

K Bhalla, J Cole, W MacLaughlin, M Baker, Z Arlin, G Graham, S Grant

Blood (1986) 68 (5): 1136–1141.

https://doi.org/10.1182/blood.V68.5.1136.1136

Published: 1986

NARROW

A Novel Role of Histone Deacetylase 11 (HDAC11) in the Regulation of IL-10 Production and Immune Tolerance Mediated by Antigen-Presenting Cells.

Enhancement of the Antigen-Presenting Cell Function of Mantle Cell Lymphomas (MCL) by Novel Molecularly Based Immunotherapeutic Strategies.

Measurement of Free Circulating Bcr-Abl Fusion Protein and Its Phosphorylation in Patients with Chronic Myeloid Leukemia.

Phosphorylation Levels of BCR-ABL, Stat5, and CrkL Proteins in Imatinib-Resistant CML Patients as Compared to Previously Untreated CML Patients: Implication of Poor Drug Binding and Activation of Alternate Pathways.

AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has Significant Activity in Imatinib-Resistant Chronic Myeloid Leukemia (CML) or Philadelphia-Chromosome Positive Acute Lymphoid Leukemia (Ph + ALL).

Discrepancy in Detecting Bcr-Abl Kinase Domain Mutations between Cells from Bone Marrow and Cells from Peripheral Blood, and Greater Concordance between Bone Marrow Cells and Plasma Free RNA.

Treatment of Antigen-Presenting Cells with Histone Deacetylase Inhibitors Represents a Novel Strategy To Overcome CD4+ T-Cell Tolerance: Divergent Effects on the IL10 and IL-12 Promoter.

Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells

High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells

Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells

Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells

Treatment with interleukin-3 plus granulocyte-macrophage colony- stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts

2'-Deoxycytidine protects normal human bone marrow progenitor cells in vitro against the cytotoxicity of 3'-azido-3'-deoxythymidine with preservation of antiretroviral activity

Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity

Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only